VOX Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.…
Industry Peers
Diagnostics & ResearchKey Statistics
About Voxel (WSE: VOX)
›
Voxel (WSE: VOX) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 356 employees.
The shares were at 152.60 PLN on 19 November 2026, down 3.4% over 52 weeks. Its 52-week range is 93.80 PLN to 167.00 PLN: the price is 8.6% below the high and 62.7% above the low.
At a market capitalisation of 1.60B PLN, it trades at 13.8 times trailing earnings and 15.6 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 61% for VOX. It pays a dividend yielding 1.66% (it pays out 43% of its earnings), against a median of 0.73% among the dividend payers in that peer group.
Voxel reports return on equity of 24.1%, an operating margin of 24.6% and revenue up 45.1% year over year.
Its debt exceeds its cash by 123.77M PLN, a debt-to-equity ratio of 0.45. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 153.07 PLN is 0.3% above the current price.